During the developmental progression of lymphoid progenitors, antigen receptor loci are assembled from variable (V), diversity (D), and joining (J) gene segments. In precursor B cells, the immunoglobulin heavy chain (Igh) locus undergoes ordered gene segment rearrangement with D H J H joining preceding V H to D H J H rearrangement. Similarly, in progenitor T lineage cells, the T cell receptor b chain is assembled from V, D, and J elements, whereas the TCRa chain is generated from the joining of V and J elements. The ordered rearrangement of the Igh locus is controlled by an insulator element, characterized by two CTCF binding sites, named the intergenic control region 1 (IGCR1), located between the V H and D H J H region. The IGCR1 helps to equalize antibody repertoires by suppressing transcription of proximal VH regions and their recombination with D H elements that have not yet joined with J H regions. Likewise, the Vk regions are segregated from the Jk regions by regulatory elements, named Cer and Sis, which antagonize transcription across the proximal Vk regions and suppress proximal VkJk recombination.
Fibrillin-1 (FBN1) is a structural component of microfibrils in the extracellular matrix that plays a role in tissue development. Genetic defects in FBN1 are associated with a number of clinical conditions including systemic sclerosis (SSc)/scleroderma. In this issue, Chen et al. report that the osteopenia in a mutant "tight skin" mouse model of SSc (in which Fbn1 deficiency is due to a partial duplication of the Fbn1 gene) is caused, at least in part, by an increase in IL-4 signaling in bone marrow mesenchymal stem cells (BMMSCs). This activation of IL-4 signaling in BMMSCs favors adipogenic differentiation and prevents osteoblast differentiation in an mTORC1-dependent manner.
Undoubtedly, this paper covers a lot of ground, from the bone pathology in this model of SSc, to the molecular pathogenesis and treatment with the mTOR inhibitor rapamycin. There is no doubt that the therapeutic aspect is the most original, exciting, and important one of this exhaustive study, mainly because it is the least expected. First of all, this paper provides a long awaited explanation for the ability of IL-4 overexpression in cells of the osteoblast lineage to cause bone loss by decreasing bone formation, an observation that was first reported by the Perlmutter group 20 years ago. This is a very stimulating paper in a rapidly evolving field for several reasons. The model of Fbn1 mutation used in this paper is not a loss of function mutation. Hence, it will be important to determine if the increase in osteogenesis seen in Fbn1 loss of function mouse models will be explained by the same or by a different mechanism. Given the opposite nature of the bone phenotype in the two mouse models this is the most urgent question to address.
In a broader sense, the fact that activating the mTORC1 pathway would down-regulate osteogenesis is interesting because it seems counterintuitive. Indeed, osteogenesis is a process that requires a continuous and high level of protein synthesis; therefore, one would anticipate that activating the mTORC1 pathway would have a beneficial effect on osteogenesis, not a deleterious one. This is what has been observed in other, albeit different, mouse models, and it will be interesting to investigate the molecular basis of the differences between the tight skin mice and other models.
This study presents a large amount of data on the role of the FBN1/TGF-b/IL4Ra/mTOR cascade in BBMSC lineage selection. As acknowledged by the authors, it is clear that there is more to this story and that it is only the beginning of a long investigation. Further work to address the two key issues highlighted above will help to elucidate the regulation of bone formation by the extracellular matrix and the mechanisms whereby IL-4 signaling in cells of the osteoblast lineage can affect bone. Chen, C., et al. 2015 . J. Exp. Med. http://dx.doi.org/10.1084 One of the most elegant master regulatory cascades in cell biology is the system of small G proteins controlling actin-based structures and coordinating these with cell polarity and cell cycle: Cdc42, Rac, and Rho. In this issue, Burbage et al. examine the role of one of these regulators, Cdc42, in B cell function using conditional gene targeting in mice. They find that this master regulator is everything it's cracked up to be-selective Cdc42 deletion in developing B cells led to a series of deficits that included decreased B cell receptor (BCR) signaling and delayed egress from the bone marrow, as well as an almost complete functional collapse when Cdc42-deficient B cells were asked to make antibodies in response to viral infection. 
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Classical studies describe how stromal cells generate-in response to growth factors-fine, spiky protrusions called filopodia to probe the environment, ruffling protrusions to allow fluid uptake, and, finally, a network of stress fibers to exert contractile forces. The Rho family of small GTPases controls these distinct F-actin structures: Cdc42 for spikes, Rac for ruffles, and Rho for contraction. The generation of such structures is important for immune cells, as actin-based protrusions are the most sensitive part of cells for antigen recognition, and contractile force is an important ingredient in ligand recognition by T and B cell receptors.
In this study, Burbage et al. define roles for Cdc42 in development and mature B cell function. The first nonredundant role of Cdc42 is in pro-B to pre-B cell differentiation. Of potential interest, this is a transition for which CD19 is required, which might entail F-actin regulated recruitment of CD19 to pre-BCR signaling clusters. The authors also suggested that Cdc42 might be required for immature B cell responses to the egress signal, sphingosine 1 phosphate (S1P), although this was not directly investigated; such decisions could involve competition between retention and egress signals, either or both of which could contribute to the phenotype. However, an earlier study found that B cell chemotaxis to CXCL12 was intact in Cdc42-deficient B cells, which suggests that retention signals are intact. The most dramatic effects of Cdc42 deficiency uncovered in this study were found in mature B cells in response to antigen. Steady state levels of IgM and IgG were low in specific pathogen-free animals. Furthermore, mice with Cdc42-deficient B cells were unable to produce IgG antibody responses to flu infection. Vaccination revealed a 1 log defect in IgM production and 3 log defects in IgG isotypes, suggesting impaired T cell-dependent responses. BCR signaling, spreading and antigen uptake were impaired, but the partial defects could not obviously account for the defects in antibody production. Consistent with earlier reports, B cells appeared to localize normally in lymphoid tissues, but by using two-photon microscopy, the present study found that Cdc42 deficient B cells moved significantly slower in lymph nodes. Furthermore, the generation of MHC-peptide complexes was strongly impaired and there was a general failure of early T-B conjugate assembly and germinal center formation. It is known that plasmablasts display a strong, sustained polarization when exiting follicles for the medulla, where they begin maturation into plasma cells. While this aspect of plasmablast behavior was not studied, there was clearly a cell autonomous defect in the differentiation of plasma cells in response to CD40 engagement independent of the defect in T-B conjugation. Cdc42 was found to play a critical role in CD40L-induced activation of AP-1, which is required to up-regulate Blimp-1, a factor known to modulate plasma cell differentiation in B cells.
The mechanisms by which Cdc42 dependent signaling contribute to B cell development, loading of MHC-peptide complexes, and AP-1 induction in plasma cells are not known. It's also unclear how extensively quantitative defects in cell polarity are linked to these functional abnormalities. The defects in immature B cell egress and B cell migration may be secondary to polarity defects, but further studies are needed to determine if responses to chemotactic signals, such as S1P, are responsible and why this pathway would be more affected than G protein-coupled receptor-dependent responses to chemokines. 
